WO2012068714A1 - Hair growth promoter - Google Patents

Hair growth promoter Download PDF

Info

Publication number
WO2012068714A1
WO2012068714A1 PCT/CN2010/078935 CN2010078935W WO2012068714A1 WO 2012068714 A1 WO2012068714 A1 WO 2012068714A1 CN 2010078935 W CN2010078935 W CN 2010078935W WO 2012068714 A1 WO2012068714 A1 WO 2012068714A1
Authority
WO
WIPO (PCT)
Prior art keywords
hair
adenine
lotion
hair growth
promoting agent
Prior art date
Application number
PCT/CN2010/078935
Other languages
French (fr)
Chinese (zh)
Inventor
陈翰民
Original Assignee
Chen Han-Min
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chen Han-Min filed Critical Chen Han-Min
Priority to JP2013534147A priority Critical patent/JP5902184B2/en
Priority to KR1020187019007A priority patent/KR20180080368A/en
Priority to PCT/CN2010/078935 priority patent/WO2012068714A1/en
Priority to KR1020137009608A priority patent/KR20130060326A/en
Priority to KR1020157032937A priority patent/KR102035812B1/en
Publication of WO2012068714A1 publication Critical patent/WO2012068714A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/14Drugs for dermatological disorders for baldness or alopecia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00Preparations for affecting hair growth

Definitions

  • the present invention relates to a hair growth promoting agent, and more particularly to a hair growth promoting agent which can maintain hair growth and increase its density.
  • BACKGROUND OF THE INVENTION As the population ages and the pressures of life increase, more and more people are facing a crisis of hair loss or baldness. According to medical research, this crisis has also caused psychological and emotional stress on the family, so most people try to find a way to effectively treat alopecia. In general, hair loss is caused by male hormones and dihydrotestosterone in hair follicles.
  • Dihydrotestosterone reduces the blood flow of hair follicles and hair dermal papillae, making the scalp nutrient insufficient or producing an oxidation reaction, so the general hair growth formula has elimination.
  • ingredients that alleviate the above symptoms for example, plus sauerkraut extract, vitamin E and its derivatives or choline derivatives to increase blood circulation of the scalp, or add amino acids such as serine or methionine, vitamins such as B6 Wait to nourish hair follicles to prevent hair loss and promote hair growth.
  • the US Food and Drug Administration proposes two components for the treatment of male alopecia, finasteride (US Patent No. 2006/0099251 A1) and minoxidil (US Patent No. 4139619).
  • Finasteride converts free testosterone to dihydrotestosterone using a 5-alpha-reductase that inhibits activity, triggering hair follicle micronization (Dallob, 1994), which was originally used to treat benign prostatic hyperplasia (BPH)
  • BPH benign prostatic hyperplasia
  • minoxidil is a vasodilator that was originally an oral drug for the treatment of hypertension (Loniten), which was found in the 1980s.
  • Puqiang has obtained FDA approval for a product containing 2% minoxidil for the treatment of alopecia and Rogaine and Regaine. The reason is due to It may cause more oxygen, blood and nutrients to enter the hair follicle by dilating blood vessels and opening potassium channels; minoxidil hair tonic is recommended to be combined with adenosine (Li, 2001) and was by A2b adenosine receptor as a way (lino, 2007), it is disclosed that adenosine also has the function of treating alopecia, but it may cause side effects, especially when minoxidil is used together with adenosine, it may cause edema, tachycardia, and difficulty breathing. , fatigue and nausea, and may lead to the formation of cancer.
  • an object of the present invention is to provide a hair growth promoting agent.
  • the present invention provides a hair growth promoting agent, the hair growth promoting agent mainly comprising: adenine or adenine salt as an active substance; and a cosmetic carrier.
  • the hair growth promoting agent is used in combination with a cosmetic carrier by adenine or adenine salts.
  • the active material accounts for 0.0001% or more by weight of the hair growth promoter.
  • the cosmetic carrier is a lubricant, a solvent, a moisturizer, a thickener, a powder or a mixture thereof.
  • the cosmetic carrier is a hair lotion, a hair lotion, a conditioner, a hair care gel, a hair styling liquid or a shampoo.
  • the invention provides an eyelash and eyebrow growth promoter, wherein the eyelash and eyebrow growth promoter are composed of: adenine or adenine salt as an active substance; and a cosmetic carrier.
  • a preferred embodiment of the above-mentioned eyelash and eyebrow growth promoter wherein the cosmetic carrier For hair tonic, hair lotion, conditioner, hair care gel, hair styling lotion or shampoo.
  • the hair loss prevention agent provided by the present invention mainly comprises: adenine or adenine salt as an active substance; and a cosmetic carrier.
  • the cosmetic carrier is a hair lotion, a hair lotion, a conditioner, a hair care gel, a hair styling solution or a shampoo.
  • the hair growth promoting agent of the present invention uses an adenine or an adenine salt as an active substance; and a cosmetic carrier, which can provide a hair styling water, a cleansing lotion, a moisturizing lotion, a hair care gel, and a hair which do not harm the human skin or the scalp.
  • a styling solution or shampoo that not only stimulates hair growth, prevents hair loss, but also promotes the growth of eyelashes and eyebrows.
  • Fig. 1 is a comparison diagram of a hair dermal mastoid cell regeneration test of the present invention.
  • the present invention provides a hair growth promoting agent mainly comprising adenine or adenine salt as an active substance and a cosmetic carrier, and the ratio of the active substance varies depending on the formulation form and the preparation method, and the composition weight thereof The preferred range of percentage is 0.0001% or more, and the hair growth promoting agent may be present in the form of a hair lotion, a cleansing lotion, a conditioner, a hair care gel, a hair styling solution or a shampoo, and is passed through a liquid, a paste or Latex-like application to the skin or scalp; in addition, the present invention comprises a cosmetic carrier which may be a carrier of a diluent, a dispersing agent or adenine to promote the distribution of the hair growth promoting agent on the skin surface, and the carrier may be in the form of a liquid.
  • a cosmetic carrier which may be a carrier of a diluent, a dispersing agent or adenine to promote the distribution of the hair growth promoting agent on the skin surface, and the
  • the hair growth promoting agent in addition to the active substance of the present invention and a cosmetic carrier, also contains additives and adjuvants commonly used in the field of cosmetics, medicine or dermatology, such as Hydrophilic or lipophilic gel, hydrophilic or lipophilic active agent, preservative, anti-resistance Agents, solvents, fragrances, fillers, For fungicides, deodorants, dyes or colorants, these additives and adjuvants are used in amounts ranging from 0.01% to 10% by weight.
  • additives and adjuvants commonly used in the field of cosmetics, medicine or dermatology, such as Hydrophilic or lipophilic gel, hydrophilic or lipophilic active agent, preservative, anti-resistance Agents, solvents, fragrances, fillers, For fungicides, deodorants, dyes or colorants, these additives and adjuvants are used in amounts ranging from 0.01% to 10% by weight.
  • the hair growth promoter of the present invention prepares a hair growth aqueous solution of four samples by different ratios, and the proportion components thereof are as shown in Table 1, and the sample thereof Preparation methods include:
  • the hair growth promoting component of the present invention has an excellent effect on hair growth.
  • the invention has the effects of preventing hair loss and promoting hair growth, and the sample 3, the sample 4 and the control group of the above configuration are applied to the scalp of 60 males with alopecia, twice a day, 1 ml portion each time, continuously applying four After the month, the human body test was conducted through a questionnaire. The results of the questionnaire test are shown in Table 3.
  • Sample 3 sample 4 control group sample 3 sample 4 control group
  • the hair growth promoting agent of the present invention contains a significant adenine or adenine salt for hair growth.
  • the eyelash cleaning lotion of the present invention is tested by a questionnaire method for human body testing.
  • the test object is to apply the sample 8, sample 9 and control group 2 of the above configuration to the eyelashes of 48 women through a cotton swab, once a day, 0.5 ml portion each time, after three months of continuous application, the questionnaire test results are shown in the table. 8 is shown.
  • the components of the eyelash cleansing lotion of the present invention contain adenine or adenine salts and have remarkable effects on eyelash growth.
  • the eyebrow cleaning lotion of the present invention is subjected to a human body test investigation through a questionnaire method, and the test object is to apply the sample 8, sample 9 and the control group 2 arranged above to the eyelashes of 60 women by a cotton swab, once a day,
  • the results of the questionnaire test are shown in Table 9 after 0.5 ml of each dose and two months of continuous application. Table 9 Test results
  • the components of the eyebrow cleansing lotion of the present invention contain adenine or adenine salts, and have remarkable effects on eyelash growth.
  • the effect of cell regeneration by adenine can be measured by measuring the number of dermal dermal protuberance cells in human hair, comparing the effects of adenosine and minoxidil (minoxidil) under the following conditions. The results are shown in Figure 1;
  • the cell culture medium of hair dermal protuberance cells contains adenine, adenosine and minoxidil (minoxidil), and the composition contains 0.002% adenine, adenosine and minoxidil (minoxidil).
  • the test method is:
  • adenine can significantly enhance the dermal dermal prominent cells of human hair.
  • the hair growth promoting agent of the present invention has a remarkable hair care effect, can improve the hair growth ability of humans or mammals, and can prevent hair from falling off.

Abstract

A hair growth promoter comprising adenine or salts of adenine as active agents and cosmetic carriers is disclosed. The amount of the active agents in the hair growth promoter is more than 0.0001wt%. The cosmetic carriers are lubricants, solvents, humectants or thickening agents. The hair growth promoter has the effect of stimulating hair growth, preventing hair loss and increasing growth of eyelash and eyebrow, and can be used in hair lotion, hair cleaning emulsion, hair moisture, hair care gel, hair setting lotion, shampoo and so on.

Description

毛发生长促进剂  Hair growth promoter
技术领域 本发明涉及一种毛发生长促进剂, 尤指一种可维持毛发生长以及增加其浓 密程度的毛发生长促进剂。 背景技术 由于现今人口老龄化以及生活压力与曰倶增, 愈来愈多的人正面临落发或 秃头的危机。 根据医学研究指出, 此危机也造成了家庭的心理与情绪压力, 故 大多数人尝试寻找有效治疗秃头症的方法。 普遍来说, 毛发脱落是由男性荷尔 蒙与毛囊中二氢睾酮所引起, 二氢睾酮会减少毛囊与毛发真皮乳状突起的血流 量, 使头皮养分不足或产生氧化反应, 故一般生发水配方具有消除或缓和上述 症状的成分, 例如, 加上獰牙菜萃取液、 维生素 E及其衍生物或酰胆碱衍生物 以增加头皮的血液循环, 或加入胺基酸如丝氨酸或蛋氨酸、 维生素, 如 B6 等 滋养毛囊以预防脱发, 促进头发生长。 BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a hair growth promoting agent, and more particularly to a hair growth promoting agent which can maintain hair growth and increase its density. BACKGROUND OF THE INVENTION As the population ages and the pressures of life increase, more and more people are facing a crisis of hair loss or baldness. According to medical research, this crisis has also caused psychological and emotional stress on the family, so most people try to find a way to effectively treat alopecia. In general, hair loss is caused by male hormones and dihydrotestosterone in hair follicles. Dihydrotestosterone reduces the blood flow of hair follicles and hair dermal papillae, making the scalp nutrient insufficient or producing an oxidation reaction, so the general hair growth formula has elimination. Or ingredients that alleviate the above symptoms, for example, plus sauerkraut extract, vitamin E and its derivatives or choline derivatives to increase blood circulation of the scalp, or add amino acids such as serine or methionine, vitamins such as B6 Wait to nourish hair follicles to prevent hair loss and promote hair growth.
美国食品药物管理局 (FDA )提出两种治疗男性秃头症的成分, 分别为非 那雄胺 (finasteride,美国专利证号 2006/0099251 A1 )以及米诺地尔 (minoxidil, 美国专利证号 4139619 ); 非那雄胺(finasteride )利用抑制活性的 5 -α-还原酶 使自由睾酮转化为二氢睾酮, 引发毛囊细微化(Dallob, 1994年), 其原本用于 治疗良性前列腺增生症(BPH ), 但后来发现也可以有效地治疗男性秃头症; 米 诺地尔 (minoxidil)是一种血管扩张剂, 原本是一种可治疗高血压的口服药物 ( Loniten ), 在 1980年代时被发现其副作用可使头发生长并抑制落发; 普强公 司获得 FDA批准上巿一种含 2 %米诺地尔 (minoxidil)的产品,用来治疗秃头症 和落发症 ( Rogaine and Regaine ), 有效的原因是由于其可能通过扩张血管与开 放钾通道, 导致更多的氧气、 血液和养分进入毛囊中; 米诺地尔 (minoxidil)生 发水被建议与腺苷一起使用( Li, 2001年),并通过 A2b腺苷作为受体途径( lino, 2007 年), 故披露了腺苷也具有治疗秃头症的功能, 但可能会产生副作用, 尤 其是当米诺地尔 (minoxidil)与腺苷一起使用时, 可能产生水肿、 心动过快、 呼 吸困难、 疲劳与恶心, 并可能会导致癌症的形成。 The US Food and Drug Administration (FDA) proposes two components for the treatment of male alopecia, finasteride (US Patent No. 2006/0099251 A1) and minoxidil (US Patent No. 4139619). Finasteride converts free testosterone to dihydrotestosterone using a 5-alpha-reductase that inhibits activity, triggering hair follicle micronization (Dallob, 1994), which was originally used to treat benign prostatic hyperplasia (BPH) However, it was later found to be effective in treating male alopecia; minoxidil is a vasodilator that was originally an oral drug for the treatment of hypertension (Loniten), which was found in the 1980s. It can grow hair and inhibit hair loss; Puqiang has obtained FDA approval for a product containing 2% minoxidil for the treatment of alopecia and Rogaine and Regaine. The reason is due to It may cause more oxygen, blood and nutrients to enter the hair follicle by dilating blood vessels and opening potassium channels; minoxidil hair tonic is recommended to be combined with adenosine (Li, 2001) and was by A2b adenosine receptor as a way (lino, 2007), it is disclosed that adenosine also has the function of treating alopecia, but it may cause side effects, especially when minoxidil is used together with adenosine, it may cause edema, tachycardia, and difficulty breathing. , fatigue and nausea, and may lead to the formation of cancer.
虽然已经尝试使用上述的各种方法, 但目前巿面上的生发水未必在头皮的 任何区域都具有充分地防止落发与促进头发生长的能力, 举例来说, 在头顶或 前额处使用非那雄胺(finasteride )与米诺地尔 (minoxidil)时, 几乎只有头顶处 可有效生出毛发; 此外, 大部分治疗必须经过很长的时间才会有效果出现, 例 如, 4至 6个月; 治疗秃头症也可通过移植毛发手术解决问题, 但手术过程中 会感到疼痛, 且无法保证一定会成功, 头发甚至需要等待数月至数年后才会再 生。 发明内容 有鉴于此, 本发明的目的在于提供一种毛发生长促进剂。  Although attempts have been made to use the various methods described above, the hair spray on the face today does not necessarily have the ability to adequately prevent hair loss and promote hair growth in any area of the scalp, for example, using phenazine at the top of the head or forehead. When amines (finasteride) and minoxidil, almost only the top of the head can effectively produce hair; in addition, most of the treatment must take a long time to have an effect, for example, 4 to 6 months; treatment of baldness The disease can also be solved by transplanting hair surgery, but it will feel pain during the operation, and there is no guarantee that it will succeed. The hair even needs to wait for several months to several years before it regenerates. SUMMARY OF THE INVENTION In view of the above, an object of the present invention is to provide a hair growth promoting agent.
本发明提供的一种毛发生长促进剂, 所述毛发生长促进剂主要包含: 腺嘌 呤或腺嘌呤盐类作为活性物质; 以及化妆品载体。  The present invention provides a hair growth promoting agent, the hair growth promoting agent mainly comprising: adenine or adenine salt as an active substance; and a cosmetic carrier.
作为上述一种毛发生长促进剂的优选方案, 其中所述毛发生长促进剂通过 腺嘌呤或腺嘌呤盐类与化妆品载体混合使用。  As a preferred embodiment of the hair growth promoting agent described above, the hair growth promoting agent is used in combination with a cosmetic carrier by adenine or adenine salts.
作为上述一种毛发生长促进剂的优选方案, 其中所述活性物质占毛发生长 促进剂重量百分比的 0.0001%以上。  As a preferred embodiment of the above hair growth promoter, the active material accounts for 0.0001% or more by weight of the hair growth promoter.
作为上述一种毛发生长促进剂的优选方案,其中所述化妆品载体为润滑剂、 溶剂、 保湿剂、 增稠剂、 粉末或其混合物。  As a preferred embodiment of the above hair growth promoter, the cosmetic carrier is a lubricant, a solvent, a moisturizer, a thickener, a powder or a mixture thereof.
作为上述一种毛发生长促进剂的优选方案, 其中所述化妆品载体, 为生发 水、 洁发乳液、 润发液、 毛发护理凝胶、 头发定型液或洗发水。  As a preferred embodiment of the above hair growth promoting agent, the cosmetic carrier is a hair lotion, a hair lotion, a conditioner, a hair care gel, a hair styling liquid or a shampoo.
本发明提供的一种眼睫毛与眉毛生长促进剂, 所述眼睫毛与眉毛生长促进 剂组成为: 腺嘌呤或腺嘌呤盐类作为活性物质; 以及化妆品载体。  The invention provides an eyelash and eyebrow growth promoter, wherein the eyelash and eyebrow growth promoter are composed of: adenine or adenine salt as an active substance; and a cosmetic carrier.
作为上述一种眼睫毛与眉毛生长促进剂的优选方案, 其中所述化妆品载体 为生发水、 洁发乳液、 润发液、 毛发护理凝胶、 头发定型液或洗发水。 A preferred embodiment of the above-mentioned eyelash and eyebrow growth promoter, wherein the cosmetic carrier For hair tonic, hair lotion, conditioner, hair care gel, hair styling lotion or shampoo.
本发明提供的一种落发防止剂, 所述落发防止剂主要包含: 腺嘌呤或腺嘌 呤盐类作为活性物质; 以及化妆品载体。  The hair loss prevention agent provided by the present invention, the hair loss prevention agent mainly comprises: adenine or adenine salt as an active substance; and a cosmetic carrier.
作为上述一种一种落发防止剂的优选方案,其中所述化妆品载体为生发水、 洁发乳液、 润发液、 毛发护理凝胶、 头发定型液或洗发水。  As a preferred embodiment of the above-mentioned hair loss preventing agent, the cosmetic carrier is a hair lotion, a hair lotion, a conditioner, a hair care gel, a hair styling solution or a shampoo.
本发明的毛发生长促进剂, 通过腺嘌呤或腺嘌呤盐类作为活性物质; 以及 化妆品载体, 可提供不伤害人体皮肤或头皮的生发水、 洁发乳液、 润发液、 毛 发护理凝胶、 头发定型液或洗发水, 其不仅具有刺激毛发生长、 防止落发, 甚 至也有促进眼睫毛与眉毛生长的功效。 附图说明 图 1为本发明的毛发真皮乳状突起细胞再生测试比较图。 具体实施方式 为了达成上述目的及功效, 下面将结合附图和实施例说明如下, 以使得本 领域的普通技术人员根据以下所述能够实施本发明。  The hair growth promoting agent of the present invention uses an adenine or an adenine salt as an active substance; and a cosmetic carrier, which can provide a hair styling water, a cleansing lotion, a moisturizing lotion, a hair care gel, and a hair which do not harm the human skin or the scalp. A styling solution or shampoo that not only stimulates hair growth, prevents hair loss, but also promotes the growth of eyelashes and eyebrows. Brief Description of the Drawings Fig. 1 is a comparison diagram of a hair dermal mastoid cell regeneration test of the present invention. BEST MODE FOR CARRYING OUT THE INVENTION In order to achieve the above objects and effects, the following description will be made in conjunction with the accompanying drawings and embodiments, so that those skilled in the art can.
首先, 本发明提供一种毛发生长促进剂, 其主要包含腺嘌呤或腺嘌呤盐类 作为活性物质以及化妆品载体, 其活性物质的比例会因配方形态、 制作方法而 有所不同, 其占成分重量百分比的较佳范围为 0.0001%以上, 该毛发生长促进 剂可以通过生发水、 洁发乳液、 润发液、 毛发护理凝胶、 头发定型液或洗发水 等形式存在, 并通过液体、 膏状或乳胶状涂抹于皮肤或头皮; 此外, 本发明包 含一化妆品载体, 可为稀释剂、 分散剂或腺嘌呤的载体, 以促进毛发生长促进 剂的配方平均分布于皮肤表面, 载体的形态可为液体或固体润滑剂、 溶剂、 保 湿剂、 增稠剂或粉末; 除了本发明的活性物质与化妆品载体外, 毛发生长促进 剂也包含常使用于化妆品、 药物或皮肤科领域中的添加剂和佐剂, 如亲水性或 亲油性凝胶剂、 亲水或亲油活性剂、 防腐剂、 抗氧化剂、 溶剂、 香料、 填料、 杀菌剂、 除臭剂、 染料或着色剂, 这些添加剂和佐剂的使用范围占总重量百分 比的 0.01 %至 10 %。 Firstly, the present invention provides a hair growth promoting agent mainly comprising adenine or adenine salt as an active substance and a cosmetic carrier, and the ratio of the active substance varies depending on the formulation form and the preparation method, and the composition weight thereof The preferred range of percentage is 0.0001% or more, and the hair growth promoting agent may be present in the form of a hair lotion, a cleansing lotion, a conditioner, a hair care gel, a hair styling solution or a shampoo, and is passed through a liquid, a paste or Latex-like application to the skin or scalp; in addition, the present invention comprises a cosmetic carrier which may be a carrier of a diluent, a dispersing agent or adenine to promote the distribution of the hair growth promoting agent on the skin surface, and the carrier may be in the form of a liquid. Or a solid lubricant, a solvent, a humectant, a thickener or a powder; in addition to the active substance of the present invention and a cosmetic carrier, the hair growth promoting agent also contains additives and adjuvants commonly used in the field of cosmetics, medicine or dermatology, such as Hydrophilic or lipophilic gel, hydrophilic or lipophilic active agent, preservative, anti-resistance Agents, solvents, fragrances, fillers, For fungicides, deodorants, dyes or colorants, these additives and adjuvants are used in amounts ranging from 0.01% to 10% by weight.
为了证明本发明中腺嘌呤或腺嘌呤盐类含量对于毛发生长能力的影响, 本 发明的毛发生长促进剂通过不同比例配制出四种样品的生发水溶液, 其比例成 分如表 1所示, 其样品配制方法包括:  In order to prove the influence of the adenine or adenine salt content on hair growth ability in the present invention, the hair growth promoter of the present invention prepares a hair growth aqueous solution of four samples by different ratios, and the proportion components thereof are as shown in Table 1, and the sample thereof Preparation methods include:
(1)将腺嘌呤硫酸与、 薄荷醇、 聚乙二醇 -40、 氢化蓖麻油、 乙醇以及部分离 子交换水混合、 搅拌后产生一溶液;  (1) mixing adenine sulfuric acid with menthol, polyethylene glycol-40, hydrogenated castor oil, ethanol, and part of the separated exchange water, and stirring to produce a solution;
(2)再将其余的离子交换水, 添加至上述溶液中, 以形成生发水溶液。  (2) The remaining ion-exchanged water is further added to the above solution to form an aqueous solution of hair growth.
表 1 生发水配置样本 1-4  Table 1 Samples of raw water configuration 1-4
Figure imgf000005_0001
Figure imgf000005_0001
(a)进行小鼠的生发试验  (a) Performing a hair growth test in mice
将上述样本 1-4涂抹于毛发生长循环已静止的小鼠身上以进行试验, 这些 小鼠已通过剪刀或剃刀将其背后的毛发剃掉, 再将样品 1至 4的生发水涂于其 背部被剃掉毛发的部位, 每十只小鼠为一组, 各组每天涂抹一次用量为 0.2 亳 升的样品, 经过 14和 28天后其毛发再生的区域比例的平均数值如表 2所示。 表 2 生发水试验结果 The above samples 1-4 were applied to mice whose hair growth cycle had been quiescent, and the mice had been shaved by scissors or a razor, and the hair of the samples 1 to 4 was applied to the back. The area where the hair was shaved was set for every ten mice, and each group was applied with a sample of 0.2 liters per day. The average value of the area of hair regeneration after 14 and 28 days was as shown in Table 2. Table 2 Results of raw water test
Figure imgf000006_0001
果, 可推知本发明的毛发生长促进成分对于毛发生长具有十分卓越的功效。
Figure imgf000006_0001
As a result, it can be inferred that the hair growth promoting component of the present invention has an excellent effect on hair growth.
(b)进行人体的生发试验  (b) conducting a hair growth test of the human body
本发明具有防止落发以及促进头发生长的效果, 将上述配置的样本 3、 样 本 4与控制组涂抹于 60位患有秃头症的男性的头皮上, 一天两次, 每次 1ml 份量, 连续涂抹四个月后, 透过问卷方式进行人体测验调查, 其问卷测验结果 如表 3所示。  The invention has the effects of preventing hair loss and promoting hair growth, and the sample 3, the sample 4 and the control group of the above configuration are applied to the scalp of 60 males with alopecia, twice a day, 1 ml portion each time, continuously applying four After the month, the human body test was conducted through a questionnaire. The results of the questionnaire test are shown in Table 3.
表 3 测验结果  Table 3 Test results
8周后 16周后  After 8 weeks, after 16 weeks
样本 3 样本 4 控制组 样本 3 样本 4 控制组  Sample 3 sample 4 control group sample 3 sample 4 control group
(n = 25) (n = 28) (η = Π) (n = 25) (n = 28) (η = Π) 头发型态 各独立组 (%,该测验组的百分比)  (n = 25) (n = 28) (η = Π) (n = 25) (n = 28) (η = Π) Hair type Independent group (%, percentage of the test group)
的改变  Change
+2 (改善) 4 (16%) 5 (18%) 0 (0%) 9 (36%) 13 (47%) 0 (0%) +2 (improvement) 4 (16%) 5 (18%) 0 (0%) 9 (36%) 13 (47%) 0 (0%)
+1 (些微改 7 (28%) 13 (46%) 2 (12%) 10 (40%) 9 (32%) 1 (6%) +1 (slightly modified 7 (28%) 13 (46%) 2 (12%) 10 (40%) 9 (32%) 1 (6%)
0 (无变化) 14 (56%) 10 (36%) 8 (47%) 6 (24%) 6 (21%) 8 (47%)0 (no change) 14 (56%) 10 (36%) 8 (47%) 6 (24%) 6 (21%) 8 (47%)
-1 (些微恶 0 (0%) 0 (0%) 5 (29%) 0 (0%) 0 (0%) 5 (29%) 化) -1 (Slightly evil 0 (0%) 0 (0%) 5 (29%) 0 (0%) 0 (0%) 5 (29%)
-2 (恶化) 0 (0%) 0 (0%) 2 (12%) 0 (0%) 0 (0%) 3 (18%) 平均分数 0.60 0.82 -0.41 1.12 1.25 -0.59 从表 3结果可知, 本发明的毛发生长促进剂含有对头发生长具有显著 腺嘌呤或腺嘌呤盐类。 -2 (deterioration) 0 (0%) 0 (0%) 2 (12%) 0 (0%) 0 (0%) 3 (18%) Average score 0.60 0.82 -0.41 1.12 1.25 -0.59 As is apparent from the results of Table 3, the hair growth promoting agent of the present invention contains a significant adenine or adenine salt for hair growth.
(c)进行洁发乳液的配置  (c) Configuration of cleansing lotion
其制备方法以及组成请参考下列以及表 4所示:  For the preparation method and composition, please refer to the following and Table 4:
(c-1)分别将第一阶段与第二阶段成分分别混合制成溶液;  (c-1) separately mixing the first stage and the second stage components into a solution;
(c-2)再将上述的溶液混合制成洁发乳液。  (c-2) The above solutions were further mixed to prepare a hair lotion.
表 4 配置洁发乳液样本 5  Table 4 Configuring a cleansing lotion sample 5
Figure imgf000007_0001
Figure imgf000007_0001
(d)进行洗发水的配置  (d) Configuration of shampoo
其制备方法以及组成请参考下列以及表 5所示:  For the preparation method and composition, please refer to the following and Table 5:
(d-1)通过一搅拌器将羟基纤维素 (hydroxycellulose )平均分布于离子交换 水中;  (d-1) uniformly distributing hydroxycellulose in ion exchange water through a stirrer;
(d-2)将上述溶液加热至 70°C后, 添加乙二胺四乙酸二纳和柠檬酸纳直到完 全溶解;  (d-2) after heating the above solution to 70 ° C, diamethylenediaminetetraacetate and sodium citrate are added until completely dissolved;
(d-3)将上述溶液添加聚季铵盐 7直到完全溶解;  (d-3) adding the above solution to the polyquaternium 7 until completely dissolved;
(d-4)将上述溶液冷却至 40 °C再加入月桂酰肌氨酸纳( Sodium laurosyl )、 月 桂酸胺丙基甜菜碱 ( lauric acid amido propylbetaine )、 ; 油酸胺丙基胺氧化物 ( Cocamidopropylamine oxide ) 与月桂酰胺 ME A ( Lauramide MEA )并且力口 以混合; (d-4) cooling the above solution to 40 ° C and then adding sodium laurosyl, lauric acid amido propylbetaine, oleic acid amine propylamine oxide (Cocamidopropylamine oxide) and lauramide ME A (Lauramide MEA) and mixed with a mouth;
(d-5)添加尿素、 尼泊金丙酯、 腺嘌呤硫酸盐、 薄荷醇与香料, 以产生洗发 水。  (d-5) Urea, propylparaben, adenine sulfate, menthol and flavor are added to produce a shampoo.
表 5 配置洗发水样本 6  Table 5 Configuring shampoo samples 6
Figure imgf000008_0001
Figure imgf000008_0001
(e)进行润发液的配置  (e) Performing the conditioning solution
其制备方法以及组成如表 6所示, 将离子交换水与聚季铵盐 7完全混合, 然后添加瓜尔羟丙基三甲基氯化铵、 二甲基 copolyol、 腺嘌呤硫酸盐和香料以 产生润发液。 表 6 配置润发液样本 7 The preparation method and composition thereof are as shown in Table 6, the ion exchange water is completely mixed with the polyquaternium 7, and then guar hydroxypropyltrimethylammonium chloride, dimethyl copolyol, adenine sulfate and perfume are added. Produce a lotion. Table 6 Configure Run Condition Sample 7
Figure imgf000009_0001
Figure imgf000009_0001
(f)进行眉毛与眼睫毛清洁乳液的配置  (f) Configuration of eyebrow and eyelash cleansing lotion
其制备方法以及组成请参考下列以及表 7所示: For the preparation method and composition, please refer to the following and Table 7:
(f-1)分别将第一阶段与第二阶段成分混合制成溶液; (f-1) mixing the first stage and the second stage components separately into a solution;
(f-2)再将上述的溶液混合制成眉毛与眼睫毛清洁乳液。 (f-2) The above solution is further mixed to form an eyebrow and eyelash cleansing lotion.
表 7 配置眉毛与眼睫毛清洁乳液样本 8与 9  Table 7 Configure eyebrow and eyelash cleansing lotion samples 8 and 9
Figure imgf000009_0002
Figure imgf000009_0002
(g)进行眼睫毛清洁乳液的人体测试  (g) Human body test for eyelash cleansing lotion
本发明的眼睫毛清洁乳液, 以下透过问卷方式以进行人体测验调查, 其测 试对象为将上述配置的样本 8、 样本 9与控制组 2通过棉花棒涂抹于 48位女性 的眼睫毛上, 一天一次, 每次 0.5ml份量, 连续涂抹三个月后, 其问卷测验结 果如表 8所示。 The eyelash cleaning lotion of the present invention is tested by a questionnaire method for human body testing. The test object is to apply the sample 8, sample 9 and control group 2 of the above configuration to the eyelashes of 48 women through a cotton swab, once a day, 0.5 ml portion each time, after three months of continuous application, the questionnaire test results are shown in the table. 8 is shown.
表 8 测验结果  Table 8 Test results
Figure imgf000010_0001
Figure imgf000010_0001
由表 8结果可知, 本发明的眼睫毛清洁乳液的成分含有腺嘌呤或腺嘌呤盐 类于眼睫毛生长具有显著的功效。  As is apparent from the results of Table 8, the components of the eyelash cleansing lotion of the present invention contain adenine or adenine salts and have remarkable effects on eyelash growth.
(h)进行眉毛清洁乳液的人体测试  (h) Human body testing of eyebrow cleansing lotion
本发明的眉毛清洁乳液, 以下透过问卷方式以进行人体测验调查, 其测试 对象为将上述配置的样本 8、 样本 9与控制组 2通过棉花棒涂抹于 60位女性的 眼睫毛上, 一天一次, 每次 0.5ml份量, 连续涂抹两个月后, 其问卷测验结果 如表 9所示。 表 9 测验结果 The eyebrow cleaning lotion of the present invention is subjected to a human body test investigation through a questionnaire method, and the test object is to apply the sample 8, sample 9 and the control group 2 arranged above to the eyelashes of 60 women by a cotton swab, once a day, The results of the questionnaire test are shown in Table 9 after 0.5 ml of each dose and two months of continuous application. Table 9 Test results
Figure imgf000011_0001
Figure imgf000011_0001
由表 9结果可知, 本发明的眉毛清洁乳液的成分中含有腺嘌呤或腺嘌呤盐 类, 对眼睫毛生长具有显著的功效。  As is apparent from the results of Table 9, the components of the eyebrow cleansing lotion of the present invention contain adenine or adenine salts, and have remarkable effects on eyelash growth.
(i)人毛发真皮乳状突起细胞再生测试  (i) Human hair dermal papilla cell regeneration test
通过腺嘌呤提升的细胞再生成效可通过衡量人毛发真皮乳状突起细胞的数 量, 在下列条件下, 比较腺嘌呤核苷与 minoxidil (米诺地尔) 的作用, 其结果 如图 1所示; 测定毛发真皮乳状突起细胞的细胞培养液中含有的腺嘌呤、 腺嘌 呤核苷与 minoxidil (米诺地尔), 组成中包含 0.002 %的腺嘌呤、 腺嘌呤核苷与 minoxidil (米诺地尔 ),其测试方法为:  The effect of cell regeneration by adenine can be measured by measuring the number of dermal dermal protuberance cells in human hair, comparing the effects of adenosine and minoxidil (minoxidil) under the following conditions. The results are shown in Figure 1; The cell culture medium of hair dermal protuberance cells contains adenine, adenosine and minoxidil (minoxidil), and the composition contains 0.002% adenine, adenosine and minoxidil (minoxidil). The test method is:
(i-1)配制 0.002 %腺嘌呤、 腺嘌呤核苷与米诺地尔 (minoxidil ), 并控制测 试毛发真皮乳状突起细胞的介质;  (i-1) formulating 0.002% adenine, adenosine, and minoxidil, and controlling the medium for measuring dermal dermal protuberance cells;
(i-2)将人毛发真皮乳状突起细胞分别植入 96格培养皿中, 其密度为 5000 个细胞 /格, 并且添加 0.1ml的培养液至各格培养皿中;  (i-2) implanting human hair dermal papilla cells into a 96-well culture dish at a density of 5000 cells/cell, and adding 0.1 ml of the culture solution to each of the culture dishes;
(i-3)在植入细胞 12、 24、 36、 48与 60小时后, 再使用视觉计数器来计算 所有细胞的数量;  (i-3) After the cells were implanted for 12, 24, 36, 48 and 60 hours, a visual counter was used to calculate the number of all cells;
(i-4)从图 1 的结果可知, 腺嘌呤可明显地提升人毛发真皮乳状突起细胞的 再生能力, 故本发明的毛发生长促进剂具有显著的护发效果, 可提升人类或哺 乳类的毛发生长能力并且能防止毛发的脱落。 (i-4) As can be seen from the results of Fig. 1, adenine can significantly enhance the dermal dermal prominent cells of human hair. The hair growth promoting agent of the present invention has a remarkable hair care effect, can improve the hair growth ability of humans or mammals, and can prevent hair from falling off.
综上所述, 以上仅为本发明的较佳实施例, 并非因此而限制本发明的专利 保护范围, 本发明的专利范围仍应以权利要求书的内容为准。  In the above, the above is only the preferred embodiment of the present invention, and the scope of the patent protection of the present invention is not limited thereto, and the scope of the invention should be determined by the content of the claims.

Claims

权利要求书 Claim
1、 一种毛发生长促进剂, 其特征在于, 所述毛发生长促进剂主要包含: 腺 嘌呤或腺嘌呤盐类作为活性物质; 以及化妆品载体。  A hair growth promoting agent, characterized in that the hair growth promoting agent mainly comprises: an adenine or an adenine salt as an active substance; and a cosmetic carrier.
2、 如权利要求 1所述的毛发生长促进剂, 其特征在于, 所述毛发生长促进 剂通过腺嘌呤或腺嘌呤盐类与化妆品载体混合使用。  The hair growth promoting agent according to claim 1, wherein the hair growth promoting agent is mixed with a cosmetic carrier by adenine or adenine salts.
3、 如权利要求 1所述的毛发生长促进剂, 其特征在于, 所述活性物质占毛 发生长促进剂重量百分比的 0.0001%以上。  The hair growth promoting agent according to claim 1, wherein the active material accounts for 0.0001% or more by weight of the hair growth promoter.
4、 如权利要求 1或 3所述的毛发生长促进剂, 其特征在于, 所迷化妆品载 体为润滑剂、 溶剂、 保湿剂、 增稠剂、 粉末或其混合物。  The hair growth promoting agent according to claim 1 or 3, wherein the cosmetic carrier is a lubricant, a solvent, a moisturizer, a thickener, a powder or a mixture thereof.
5、 如权利要求 1所述的毛发生长促进剂, 其特征在于, 所述化妆品裁体, 为生发水、 洁发乳液、 润发液、 毛发护理凝胶、 头发定型液或洗发水。  The hair growth promoting agent according to claim 1, wherein the cosmetic body is a hair lotion, a hair lotion, a hair lotion, a hair care gel, a hair styling liquid or a shampoo.
6、 一种眼睫毛与眉毛生长促进剂, 其特征在于, 所述眼睫毛与眉毛生长促 进剂的组成为:: 腺嘌呤或腺嘌呤盐类作为活性物质; 以及化妆品载体。  6. An eyelash and eyebrow growth promoter, characterized in that the composition of the eyelash and eyebrow growth promoter is: adenine or adenine salt as an active substance; and a cosmetic carrier.
7、 如权利要求 6所述的眼睫毛与眉毛生长促进剂, 其特征在于, 所述化妆 品载体为生发水、 洁发乳液、 润发液、 毛发护理凝胶、 头发定型液或洗发水。  The eyelash and eyebrow growth promoter according to claim 6, wherein the cosmetic carrier is a hair lotion, a hair lotion, a conditioner, a hair care gel, a hair styling solution or a shampoo.
8、 一种落发防止剂,.其特征在于, 所述落发防止剂主要包含: 腺嘌呤或腺 嘌呤盐类作为活性物质; 以及化妆品载体。  A hair loss preventing agent, characterized in that the hair loss preventing agent mainly comprises: adenine or an adenine salt as an active material; and a cosmetic carrier.
9、 如权利要求 8所述的落发防止剂, 其特征在于, 所述化妆品载体为生发 水、 洁发乳液、 润发液、 毛发护理凝胶、 头发定型液或洗发水。  The hair loss preventing agent according to claim 8, wherein the cosmetic carrier is a hair lotion, a hair lotion, a conditioner, a hair care gel, a hair styling solution or a shampoo.
12 12
更正页 (细则第 91条)  Correction page (Article 91)
PCT/CN2010/078935 2010-11-22 2010-11-22 Hair growth promoter WO2012068714A1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP2013534147A JP5902184B2 (en) 2010-11-22 2010-11-22 Hair growth promoter, eyelash and eyebrow growth promoter, and hair loss inhibitor
KR1020187019007A KR20180080368A (en) 2010-11-22 2010-11-22 Hair growth promoter
PCT/CN2010/078935 WO2012068714A1 (en) 2010-11-22 2010-11-22 Hair growth promoter
KR1020137009608A KR20130060326A (en) 2010-11-22 2010-11-22 Hair growth promoter
KR1020157032937A KR102035812B1 (en) 2010-11-22 2010-11-22 Hair growth promoter

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2010/078935 WO2012068714A1 (en) 2010-11-22 2010-11-22 Hair growth promoter

Publications (1)

Publication Number Publication Date
WO2012068714A1 true WO2012068714A1 (en) 2012-05-31

Family

ID=46145345

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2010/078935 WO2012068714A1 (en) 2010-11-22 2010-11-22 Hair growth promoter

Country Status (3)

Country Link
JP (1) JP5902184B2 (en)
KR (3) KR102035812B1 (en)
WO (1) WO2012068714A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113827608A (en) * 2021-09-18 2021-12-24 福州博德新材料科技有限公司 Purine nucleoside-containing efficient minoxidil hair-growing tincture and preparation method thereof

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5982070B1 (en) * 2014-10-09 2016-08-31 株式会社メディプロデュース Eyelash cleaning agent

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1646078A (en) * 2002-04-09 2005-07-27 大塚制药株式会社 Composition for cell proliferation
CN1878530A (en) * 2003-11-11 2006-12-13 株式会社资生堂 Method and composition for hair thickening
WO2007074602A1 (en) * 2005-12-26 2007-07-05 Lion Corporation Cosmetic for scalp and hair
CN101217999A (en) * 2005-07-08 2008-07-09 宝洁公司 Personal care compositions and methods for the beautification of mammalian skin and hair

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4139619A (en) 1976-05-24 1979-02-13 The Upjohn Company 6-Amino-4-(substituted amino)-1,2-dihydro-1-hydroxy-2-iminopyrimidine, topical compositions and process for hair growth
JP2855274B2 (en) * 1989-10-19 1999-02-10 株式会社コーセー Hair restoration
JPH06128125A (en) * 1992-10-14 1994-05-10 Kose Corp Hair tonic
IS6633A (en) 2002-11-22 2004-05-23 Omega Farma Ehf. Compositions of finasteride tablets
JP2006076984A (en) * 2004-09-07 2006-03-23 Kaoru Suzuki Hair-growing/restoring agent
JP2006290767A (en) * 2005-04-07 2006-10-26 Lucia:Kk Hair-fostering/growing agent
JP2007045712A (en) * 2005-08-05 2007-02-22 Lion Corp Scalp and hair cosmetic
DE102006042231A1 (en) * 2006-09-06 2008-03-27 Henkel Kgaa Agent containing biochinones and purine or purine derivatives
JP2010184916A (en) * 2009-02-13 2010-08-26 Pias Arise Kk Hair growth promoter

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1646078A (en) * 2002-04-09 2005-07-27 大塚制药株式会社 Composition for cell proliferation
CN1878530A (en) * 2003-11-11 2006-12-13 株式会社资生堂 Method and composition for hair thickening
CN101217999A (en) * 2005-07-08 2008-07-09 宝洁公司 Personal care compositions and methods for the beautification of mammalian skin and hair
WO2007074602A1 (en) * 2005-12-26 2007-07-05 Lion Corporation Cosmetic for scalp and hair

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113827608A (en) * 2021-09-18 2021-12-24 福州博德新材料科技有限公司 Purine nucleoside-containing efficient minoxidil hair-growing tincture and preparation method thereof

Also Published As

Publication number Publication date
JP2013540135A (en) 2013-10-31
KR20180080368A (en) 2018-07-11
KR102035812B1 (en) 2019-10-23
KR20130060326A (en) 2013-06-07
JP5902184B2 (en) 2016-04-13
KR20150136544A (en) 2015-12-07

Similar Documents

Publication Publication Date Title
US5656264A (en) Method for promoting hair growth
JP4195763B2 (en) Hair lotion with improved properties in protecting hair and preventing hair loss as well as exogenous effects of androgenic alopecia and resulting reduction in hair loss
CN101291651B (en) External composition for hair growth
EP0540854B1 (en) Preparation for promoting hair growth
JPH0558851A (en) Trichogenous and hair-growing agent
EP0659080B1 (en) Method for the treatment of hair loss
CN105106027B (en) Hair growth promoting agents
JP5902184B2 (en) Hair growth promoter, eyelash and eyebrow growth promoter, and hair loss inhibitor
US8187643B2 (en) Shampoo formulation for treatment of hair loss and method of use
JPH03167113A (en) Hair regenerating agent
JP2001192322A (en) Cosmetic for hair
US10543227B2 (en) Hair growth composition
US9126056B2 (en) Method of promoting hair growth
JP2000026269A (en) Cosmetic
TW201143803A (en) Hair growth promoting composition
CN112043627B (en) Amino acid solution composition for hair growth and preparation method thereof
JP3496896B2 (en) Hair restorer and hair cosmetic
JPH1077216A (en) Hair-restoring cosmetic material
JP2000016920A (en) Hair tonic cosmetic
JP3717676B2 (en) Hair nourishing
JPH03167111A (en) Hair regenerating agent
ES2784026T3 (en) Non-therapeutic use of a composition to promote hair growth
CA2874288A1 (en) Composition for hair growth
JPH1112134A (en) Composition for head
JP2000281537A (en) Hair tonic cosmetic

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10859933

Country of ref document: EP

Kind code of ref document: A1

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
ENP Entry into the national phase

Ref document number: 20137009608

Country of ref document: KR

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 2013534147

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 10859933

Country of ref document: EP

Kind code of ref document: A1